Sign In
Buy LGVN
$0.80
-0.0197 (-2.40%)
At Close: Jun 22, 2026
Longeveron stock up 15.5% premarket after positive results in trial of treatment for rare congenital heart defect in infants
08:41am, Tuesday, 09'th May 2023
Longeveron Inc.'s stock LGVN rocketed 15.5% in premarket trade Tuesday, after the biotech said its Lomecel-B for the treatment of a congenital heart defect in infants (Hypoplastic Left Heart Syndrome)
Longeveron to Announce First Quarter 2023 Financial Results on May 12, 2023
08:30am, Monday, 08'th May 2023
MIAMI, May 08, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, to
Longeveron Inc. (LGVN) Q4 2022 Earnings Call Transcript
06:40pm, Friday, 10'th Mar 2023
Longeveron Inc. (NASDAQ:LGVN ) Q4 2022 Results Conference Call March 10, 2023 8:30 AM ET Company Participants James Clavijo - CFO Wa'el Hashad - CEO Dr. Chris Min - Chief Medical Officer Conference Ca
Longeveron to Announce Fourth Quarter and Full Year Financial Results on March 10, 2023
08:30am, Monday, 06'th Mar 2023
Live conference call on Friday, March 10 at 8:30 a.m. ET Live conference call on Friday, March 10 at 8:30 a.m. ET
3 Penny Stocks That Could Rise 500% in 2023
11:37am, Friday, 13'th Jan 2023
In November 2021, I made an outlandish effort to pick 5 cheap stocks that could double within a month. Few companies rise 100%, and even fewer can do it in the time it takes to properly pickle a cucum
Longeveron to Participate in Upcoming 2022 Investor Conferences
04:30pm, Tuesday, 29'th Nov 2022
MIAMI, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, t
Longeveron Inc. (LGVN) Q3 2022 Earnings Call Transcript
10:39am, Monday, 14'th Nov 2022
Longeveron Inc. (NASDAQ:LGVN ) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Representatives Dr. Chris Min - Interim Chief Executive Officer, Chief Medical Officer Dr. Joshua H
Longeveron to Announce Third Quarter 2022 Financial Results on November 14, 2022
09:06am, Monday, 07'th Nov 2022
Live conference call on Monday, November 14 at 8:30 a.m. EST Live conference call on Monday, November 14 at 8:30 a.m. EST
Longeveron to Present at the Annual Dawson James Small Cap Growth Conference
08:30am, Wednesday, 05'th Oct 2022
MIAMI, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, a
Why Is Longeveron (LGVN) Stock on the Move Today?
12:13pm, Wednesday, 31'st Aug 2022
Source: shutterstock.com/Anastasia Zagoruyko Longeveron (NASDAQ: LGVN ) stock is on the move Wednesday after the FDA granted its fast-track designation for Lomecel-B. Lomecel-B is a allogeneic, bone m
Longeveron Receives Intent to Grant Notice from the European Patent Office for Methods to Monitor Efficacy of Lomecel-B™ Cell Therapy Through Levels of Vascular Biomarker
12:33pm, Thursday, 25'th Aug 2022 InvestorsHub
Longeveron Receives Intent to Grant Notice from the European Patent Office for Methods to Monitor Efficacy of Lomecel-B™ Cell Therapy Through Levels of Vascular Biomarker
Issued claims will protect use of a biomarker to assess response to Lomecel-B in patients with blood vessel dysfunction.
Miami, Florida – August 25, 2022 -- InvestorsHub NewsWire -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology compa...
Longeveron Inc. (LGVN) CEO Chris Min on Q2 2022 Results - Earnings Call Transcript
02:02am, Sunday, 14'th Aug 2022
Longeveron Inc. (NASDAQ:LGVN ) Q2 2022 Earnings Conference Call August 12, 2022 8:30 AM ET Company Participants Elsie Yau - Stern Investor Relations Chris Min - Interim Chief Executive Officer & Chief
Longeveron to Announce Second Quarter 2022 Financial Results on August 12, 2022
08:30am, Monday, 08'th Aug 2022
Live conference call on Friday, August 12 at 8:30 a.m. EST Live conference call on Friday, August 12 at 8:30 a.m. EST
Longeveron Inc. (LGVN) CEO Geoff Green on Q1 2022 Results - Earnings Call Transcript
02:16pm, Tuesday, 17'th May 2022
Longeveron Inc. (NASDAQ:LGVN ) Q1 2022 Earnings Conference Call May 13, 2022 8:30 AM ET Company Participants Elsie Yau - Stern Investor Relations, IR Geoff Green - CEO Chris Min - Chief Medical Office
Longeveron to Announce First Quarter 2022 Financial Results on May 13, 2022
08:30am, Monday, 09'th May 2022
Live conference call at 8:30 a.m. EST Live conference call at 8:30 a.m. EST
